MKI67 and parathyroid gland carcinoma: Although an overlap between the two groups exists, the current WHO classification guidelines concerning parathyroid carcinoma suggests that tumours with Ki-67 counts greater than 5% should be subject to closer followup due to an increased risk of malignancy [3, 7].